Insulet Corp.

Insulet Corp. is an American medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. The company is engaged in the development, manufacture, and sale of insulin infusion systems used by people with insulin-dependent diabetes. Its products are distributed to domestic and international markets. The firm’s work is based on the results of medical studies that have demonstrated the superiority of insulin pump therapy over multiple daily insulin injections. Advantages include better glycaemic control, fewer hypoglycaemic events, reduced glycaemic variability, and improved quality of life. The company produces devices that make daily insulin pump therapy simpler, more convenient, and more affordable. The company offers a device known as the OmniPod, an automated, wearable, tubeless, and seamless system of insulin delivery that eliminates many of the problems patients sometimes encounter with conventional pump delivery systems. The OmniPod is small, discreet, and lightweight. It works by adhering directly to the patient’s skin, supporting virtually pain-free insertion. Automation of insulin delivery can be programmed using a handheld, wireless device. Insulet Corp trades on the NASDAQ under the stock ticker PODD. Add this medical technology company to your watchlist here on eToro and track PODD price movements.